Cargando…
Validating a novel three-times-weekly post-hemodialysis ceftriaxone regimen in infected Indigenous Australian patients—a population pharmacokinetic study
OBJECTIVES: To describe the total and unbound population pharmacokinetics of a 2 g three-times-weekly post-dialysis ceftriaxone regimen in Indigenous Australian patients requiring hemodialysis. METHODS: A pharmacokinetic study was carried out in the dialysis unit of a remote Australian hospital. Adu...
Autores principales: | Tsai, Danny, Zam, Betty B, Tongs, Carleigh, Chiong, Fabian, Sajiv, Cherian, Pawar, Basant, Ashok, Aadith, Cooper, Brynley P, Tong, Steven Y C, Janson, Sonja, Wallis, Steven C, Roberts, Jason A, Parker, Suzanne L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393936/ https://www.ncbi.nlm.nih.gov/pubmed/37367723 http://dx.doi.org/10.1093/jac/dkad190 |
Ejemplares similares
-
Lessons learned from a periodontal intervention to reduce progression of chronic kidney disease among Aboriginal Australians
por: Jamieson, Lisa M., et al.
Publicado: (2020) -
“Looking back to my family”: Indigenous Australian patients’ experience of hemodialysis
por: Anderson, Kate, et al.
Publicado: (2012) -
Reversible Ceftriaxone-Induced Pseudolithiasis in an Adult Patient with Maintenance Hemodialysis
por: Shima, Aya, et al.
Publicado: (2015) -
Study Protocol - Accurate assessment of kidney function in Indigenous Australians: aims and methods of the eGFR Study
por: Maple-Brown, Louise J, et al.
Publicado: (2010) -
Two cases of ceftriaxone‐induced encephalopathy treated by hemoperfusion in hemodialysis patients
por: Onogi, Chikao, et al.
Publicado: (2022)